FDA Inspection
Amneal Pharmaceuticals, LLCAmneal Pharmaceuticals, LLC – FDA Inspection, Mar 28, 2025
Record Details
This FDA Inspection record concerns Amneal Pharmaceuticals, LLC, with an inspection on March 28, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a5536a0b-4d17-443a-8dbf-ffff75e7eb54
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1256805
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Amneal Pharmaceuticals, LLC
9| Date | Classification | Office | Project area |
|---|---|---|---|
| April 30, 2026 | Not classified | New Jersey District Office | |
| November 21, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 10, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 19, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 6, 2018 | VAI | New Jersey District Office | Generic Drug Evaluation |
Other documents for Amneal Pharmaceuticals, LLC
- FDA Inspection 1309420 - 2026-04-30
- FDA Inspection 1226102 - 2023-11-21
- FDA Inspection 1162045 - 2022-02-10
- FDA Inspection 1075997 - 2018-10-19
- FDA Inspection 1047538 - 2018-04-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.